DroneShield's Institutional Backing Collides With a 71% Drawdown From Its Peak

DroneShield's shares fell 71% from October high despite A$180M cash and JPMorgan, Citigroup stakes. RfRecon launch and ASIC review are key.

The arithmetic at DroneShield is getting harder to reconcile. The Australian counter-drone specialist has guided to full-year revenue of A$250–270 million, holds A$180 million in cash with zero debt, and has watched two of Wall Street's biggest banks build positions above the five-percent disclosure threshold. Yet the share price sits at €1.08, down 40 percent since January 1 and a full 71 percent below the 52-week high of €3.79 touched on October 1.

That gap between the fundamental story and the market's verdict is the central tension for anyone holding the stock. The answer to why it persists may come down to a single product launch and a single regulatory review — neither of which has reached a conclusion.

The RfRecon test

The immediate catalyst on the calendar is RfRecon, a hardware platform unveiled in August that management has flagged for first sales in the second half of the year. Whether that product converts from announcement to actual purchase orders will determine whether DroneShield's growth trajectory holds or whether its widening losses become a structural problem rather than a growth-phase cost.

The stakes are visible in the half-year numbers. Revenue for H1 2026 came in at A$125.8 million, up 74 percent year over year, with committed revenue reaching A$240.4 million as of August 21 — already ahead of the prior year's total. But the bottom line tells a different story: a net loss of A$32.2 million versus a profit of A$2.1 million in the same period a year earlier. Operating EBITDA swung from a positive A$8.0 million to a loss of A$12.4 million.

The market's reaction to that combination was negative, and the technical picture remains weak. The stock trades 40 percent below its 200-day moving average and 18 percent under the 50-day average of €1.32. The relative strength index of 38.7 points to oversold rather than overbought conditions, while annualized 30-day volatility of 87 percent underscores how sharply the market reacts to news flow.

Recurring revenue as the pivot

The metric that will define the next several months is the share of recurring revenue in the mix. In H1, that figure reached 9.2 percent of total sales — roughly A$11.5 million — supported by an installed base of 4,100 software-capable devices. A year earlier, the recurring share stood at about 3 percent.

For a business historically built on discrete hardware orders, that shift toward predictable income streams matters more than the headline growth rate. If the recurring component climbs meaningfully, the model gains planning visibility and could justify richer valuations despite current losses. If it stalls in the low single digits, DroneShield remains a project-driven hardware vendor with volatile margins — and the expanded losses start to look like a margin problem rather than an investment phase.

RfRecon is the immediate test case for that transition. Success would support both top-line growth and the recurring-revenue ratio; failure or delay would leave the bears in control.

Institutional conviction amid the noise

Against that uncertain backdrop, the August filings from JPMorgan Chase and Citigroup-affiliated entities stand out. Both reported increased stakes, with Citigroup crossing the five-percent disclosure threshold. The purchases came during a period when the stock ranked among the most heavily traded names on the Australian benchmark index.

For long-horizon investors, the balance sheet provides the rationale. The A$180 million cash position and debt-free status fund the planned manufacturing expansion — including a new Sydney facility and the company's first European-produced hardware — without requiring external capital. A company with that kind of cushion and a rising share of contracted revenue carries a different risk profile than a pure project-order business.

The regulatory overhang

What the institutions cannot control is the Australian Securities and Investments Commission's ongoing review of DroneShield's earlier disclosures and trading activity. The company continues to cooperate with the regulator, according to media reports, but no conclusion has been announced. That unresolved question keeps a discount embedded in the share price regardless of operational progress.

The path forward is reasonably clear even if the destination is not. The confirmed guidance range of A$250–270 million and the committed-revenue backlog provide a solid operational base. Whether the market rewards it depends on two variables: the pace of RfRecon commercialization in the second half, and the outcome of the ASIC review. The first reported RfRecon sales will be the earliest concrete signal — and the moment when investors can judge whether the product launch becomes a genuine second leg or remains a presentation slide.